LXRX Return on Tangible Equity | LEXICON PHARMACEUTICALS, INC.

LEXICON PHARMACEUTICALS, INC. (LXRX) Return on Tangible Equity

2026-06-30: Return Tang Equity -55.43%.
2026-03-31: Return Tang Equity -18.82%.
2025-12-31: Return Tang Equity -116.32%.
2025-09-30: Return Tang Equity -122.68%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-55.43%
2026-03-31	-18.82%
2025-12-31	-116.32%
2025-09-30	-122.68%
2025-06-30	-185.05%
2025-03-31	-301.67%
2024-12-31	-245.32%
2024-09-30	-189.40%
2024-06-30	-115.02%
2024-03-31	-86.19%
2023-12-31	-613.91%
2023-09-30	-209.77%
2023-06-30	-107.06%
2023-03-31	-464.13%
2022-12-31	-192.84%
2022-09-30	-121.69%
2022-06-30	-1473.08%
2022-03-31	-317.44%
2021-12-31	-177.88%
2021-09-30	-93.50%
2021-06-30	52.19%
2021-03-31	-14.64%
2020-12-31	-63.59%
2020-09-30	-445.75%
2020-06-30	-52.39%
2020-03-31	-899.80%
2019-12-31	246.27%
2019-09-30	166.68%
2019-06-30	67.98%
2019-03-31	89.98%
2018-12-31	130.42%
2018-09-30	129.73%
2018-06-30	177.61%
2018-03-31	312.34%
2017-12-31	-25893.26%
2017-09-30	-363.87%
2017-06-30	-207.87%
2017-03-31	-145.96%
2016-12-31	-106.90%
2016-09-30	-15.83%
2016-06-30	-12.46%
2016-03-31	-5.51%
2015-12-31	-1.94%
2015-09-30	-61.52%
2015-06-30	-53.27%
2015-03-31	-45.78%
2014-12-31	-41.88%
2014-09-30	-344.87%
2014-06-30	-146.88%
2014-03-31	-113.25%
2013-12-31	-82.89%
2013-09-30	-79.04%
2013-06-30	-64.19%
2013-03-31	-53.79%
2012-12-31	-49.61%
2012-09-30	-57.24%
2012-06-30	-57.77%
2012-03-31	-51.89%
2011-12-31	-45.93%
2011-09-30	-84.34%
2011-06-30	-71.35%
2011-03-31	-60.27%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-116.32%
2024-12-31	-245.32%
2023-12-31	-613.91%
2022-12-31	-192.84%
2021-12-31	-177.88%
2020-12-31	-63.59%
2019-12-31	246.27%
2018-12-31	130.42%
2017-12-31	-25893.26%
2016-12-31	-106.90%
2015-12-31	-1.94%
2014-12-31	-41.88%
2013-12-31	-82.89%
2012-12-31	-49.61%
2011-12-31	-45.93%
2010-12-31	-50.26%
2009-12-31	-50.63%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
GYRE THERAPEUTICS, INC. (GYRE)	United States	$0.818B	-24.71
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
GERON CORP (GERN)	United States	$0.803B	-12.14
Aclaris Therapeutics, Inc. (ACRS)	United States	$0.792B	-9.78
Olema Pharmaceuticals, Inc. (OLMA)	United States	$0.790B	-5.35
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
Wave Life Sciences, Inc. (WVE)		$0.780B	-5.56
Design Therapeutics, Inc. (DSGN)	United States	$0.766B	-12.78